TABLE 1.

Serogroup 36 isolates identified in the Global Pneumococcal Sequencing project

	Strain information				Host information			Epidemiology
Isolate name	cps	Serotypeb	Capsule typec	MLSTd	Sourcee	Gender	Age (yrs)	Country	Isolation yr	Calculated
	typea									Prevalencef
GPS_NP_1196	36X	36	36B	8150	NP swab	Male	Unknown	Nepal	2009	0.25%
GPS_US_PATH4269	36X	36	36B	6499	NP swab	Unknown	Unknown	Ethiopia	Unknown	1.11%
GPS_RU_10	36	16/36	36A	4841	CSF	Female	59	Russia	2012	1.13%
GPS_IN_PN17	36	9	36A	11394	Blood	Male	1	India	2011	0.62%
GPS_IN_PO_H45	36	36	36A	Unknown	NP swab	Female	55	India	2016
GPS_IN_PO_H151	36	28F	36A	Unknown	NP swab	Female	67	India	2016

^aAccording to genome sequence alignment to reference capsule biosynthetic (cps) locus nucleotide sequences.

^bAccording to quellung reaction or latex agglutination using reference antisera.

^cCapsule type name given in the current study.

^dMLST, multilocus sequence typing.

^eNP, nasopharynx; CSF, cerebrospinal fluid.

^fPercentage of total GPS project isolates from the respective country putatively expressing the capsule type.